Identifying and correcting epigenetics measurements for systematic sources of variation
Open Access
- 21 March 2018
- journal article
- research article
- Published by Springer Nature in Clinical Epigenetics
- Vol. 10 (1) , 38
Abstract
Methylation measures quantified by microarray techniques can be affected by systematic variation due to the technical processing of samples, which may compromise the accuracy of the measurement process and contribute to bias the estimate of the association under investigation. The quantification of the contribution of the systematic source of variation is challenging in datasets characterized by hundreds of thousands of features. In this study, we introduce a method previously developed for the analysis of metabolomics data to evaluate the performance of existing normalizing techniques to correct for unwanted variation. Illumina Infinium HumanMethylation450K was used to acquire methylation levels in over 421,000 CpG sites for 902 study participants of a case-control study on breast cancer nested within the EPIC cohort. The principal component partial R-square (PC-PR2) analysis was used to identify and quantify the variability attributable to potential systematic sources of variation. Three correcting techniques, namely ComBat, surrogate variables analysis (SVA) and a linear regression model to compute residuals were applied. The impact of each correcting method on the association between smoking status and DNA methylation levels was evaluated, and results were compared with findings from a large meta-analysis. A sizeable proportion of systematic variability due to variables expressing ‘batch’ and ‘sample position’ within ‘chip’ was identified, with values of the partial R2 statistics equal to 9.5 and 11.4% of total variation, respectively. After application of ComBat or the residuals’ methods, the contribution was 1.3 and 0.2%, respectively. The SVA technique resulted in a reduced variability due to ‘batch’ (1.3%) and ‘sample position’ (0.6%), and in a diminished variability attributable to ‘chip’ within a batch (0.9%). After ComBat or the residuals’ corrections, a larger number of significant sites (k = 600 and k = 427, respectively) were associated to smoking status than the SVA correction (k = 96). The three correction methods removed systematic variation in DNA methylation data, as assessed by the PC-PR2, which lent itself as a useful tool to explore variability in large dimension data. SVA produced more conservative findings than ComBat in the association between smoking and DNA methylation.Keywords
Funding Information
- Fondation de France (2015 00060737)
- Institut National Du Cancer (2012-070, 2012-070)
- Seventh Framework Programme (260791)
- FP7 People: Marie-Curie Actions
- Association pour la Recherche sur le Cancer
- Medical Research Council (MC_UU_12015/1 MC_UU_12015/2, MR/L00002/1)
- Universitetet i Tromsø
- Cancerfonden
- Vetenskapsrådet
- Västerbotten Läns Landsting
- Skåne Läns Landsting
- Hellenic Health Foundation
This publication has 41 references indexed in Scilit:
- Review of processing and analysis methods for DNA methylation array dataBritish Journal of Cancer, 2013
- A beta-mixture quantile normalization method for correcting probe design bias in Illumina Infinium 450 k DNA methylation dataBioinformatics, 2012
- Distinct DNA methylomes of newborns and centenariansProceedings of the National Academy of Sciences, 2012
- The sva package for removing batch effects and other unwanted variation in high-throughput experimentsBioinformatics, 2012
- GuiTope: an application for mapping random-sequence peptides to protein sequencesBMC Bioinformatics, 2012
- High density DNA methylation array with single CpG site resolutionGenomics, 2011
- Relationship of folate, vitamin B12 and methylation of insulin-like growth factor-II in maternal and cord bloodEuropean Journal of Clinical Nutrition, 2011
- Comparison of Beta-value and M-value methods for quantifying methylation levels by microarray analysisBMC Bioinformatics, 2010
- A comparison of batch effect removal methods for enhancement of prediction performance using MAQC-II microarray gene expression dataThe Pharmacogenomics Journal, 2010
- A general framework for multiple testing dependenceProceedings of the National Academy of Sciences, 2008